Morepen Laboratories Ltd Share Price ₹50.1

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Morepen Laboratories Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	364	401	422	445	423	455	438	453	466	425	412	484	485
Expenses +	348	375	388	394	375	404	394	417	424	401	381	438	460
Operating Profit	16	26	34	51	48	52	44	36	42	24	31	46	24
OPM %	4%	7%	8%	11%	11%	11%	10%	8%	9%	6%	7%	10%	5%
Other Income +	3	2	3	4	4	3	5	5	5	4	30	4	8
Interest	1	0	0	2	1	1	1	1	5	4	4	4	4
Depreciation	7	8	8	8	10	6	2	5	16	9	11	10	6
Profit before tax	11	21	29	44	42	48	46	35	26	16	46	35	23
Tax %	26%	29%	26%	27%	32%	25%	24%	24%	21%	26%	10%	22%	33%
Net Profit +	8	15	21	32	29	36	35	27	20	11	41	28	16
EPS in Rs	0.16	0.29	0.42	0.63	0.55	0.71	0.64	0.49	0.37	0.20	0.75	0.50	0.29

Financials of Morepen Laboratories Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	401	485	595	607	769	853	1,188	1,547	1,418	1,690	1,812	1,806
Expenses +	352	424	534	542	701	785	1,070	1,410	1,338	1,532	1,638	1,680
Operating Profit	48	62	61	65	68	69	119	137	80	159	174	126
OPM %	12%	13%	10%	11%	9%	8%	10%	9%	6%	9%	10%	7%
Other Income +	1	-3	4	4	4	9	12	10	6	14	18	47
Interest	9	10	8	4	2	2	2	-7	2	4	8	16
Depreciation	39	35	34	34	40	37	30	28	28	33	29	36
Profit before tax	2	13	24	30	29	39	99	127	56	135	155	120
Tax %	6%	-1%	0%	0%	1%	14%	1%	20%	31%	29%	24%	20%
Net Profit +	2	13	24	30	29	34	97	102	39	97	118	96
EPS in Rs	0.05	0.28	0.53	0.66	0.64	0.75	2.16	2.13	0.76	1.88	2.15	1.73
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	9%	12%

Financials of Morepen Laboratories Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	90	90	90	90	90	90	90	96	102	102	110	110
Reserves	78	91	106	136	163	194	335	483	651	745	1,047	1,137
Borrowings +	201	187	169	134	132	133	17	19	25	29	105	208
Other Liabilities +	121	156	173	226	230	246	416	473	332	417	517	482
Total Liabilities	489	524	538	586	615	663	858	1,070	1,110	1,293	1,778	1,936
Fixed Assets +	322	297	272	264	236	216	225	252	267	307	489	513
CWIP	0	0	0	0	0	0	2	14	17	24	28	22
Investments	0	0	0	0	0	1	1	0	0	1	85	124
Other Assets +	167	227	266	321	379	446	631	804	827	960	1,176	1,277
Total Assets	489	524	538	586	615	663	858	1,070	1,110	1,293	1,778	1,936

Financials of Morepen Laboratories Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	51	50	41	63	17	11	51	-60	-91	73	32
Cash from Investing Activity +	-32	-27	-14	-27	-13	-12	-70	-32	-47	-83	-322
Cash from Financing Activity +	-19	-27	-24	-38	-0	5	47	66	144	5	300
Net Cash Flow	-0	-4	3	-1	4	4	28	-26	6	-5	10
Free Cash Flow	46	41	31	37	6	-6	10	-127	-137	-8	-182
CFO/OP	105%	81%	66%	98%	26%	25%	44%	-26%	-94%	70%	40%

Financials of Morepen Laboratories Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	51	66	57	73	64	59	56	59	68	70	65	67
Inventory Days	55	51	65	76	69	91	82	96	87	85	94	88
Days Payable	126	140	125	173	124	113	98	90	87	101	114	103
Cash Conversion Cycle	-20	-23	-3	-24	9	37	40	65	69	54	45	53
Working Capital Days	-20	-10	-86	-62	-34	-8	17	55	98	94	107	122
ROCE %	3%	8%	9%	9%	8%	10%	23%	23%	8%	17%	15%	8%